These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8402746

  • 1. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F, Seguro C, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A.
    Cardiologia; 1993 Jun; 38(6):369-76. PubMed ID: 8402746
    [Abstract] [Full Text] [Related]

  • 2. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F, Seguro C, Pargentino E.
    Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
    [Abstract] [Full Text] [Related]

  • 3. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F, Seguro C, Lai C, Orani E, Soro A, Onnis E, Cherchi A.
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [Abstract] [Full Text] [Related]

  • 4. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA, Shlyakhto EV, Konrady AO, Macsimova TA, Zaharov DV, Rudomanov OG.
    Med Sci Monit; 2000 Nov; 6(2):309-13. PubMed ID: 11208328
    [Abstract] [Full Text] [Related]

  • 5. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
    Sau F, Seguro C, Pili G, Basciu M, Siddi PP, Tamponi R, Cherchi A.
    Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
    [Abstract] [Full Text] [Related]

  • 6. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E, Patruno N, Natale E, Marsocci A, Gambelli G.
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [Abstract] [Full Text] [Related]

  • 7. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G.
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [Abstract] [Full Text] [Related]

  • 8. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 9. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH, Myers MG, Joyner CD, Toal CB.
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 12. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
    Sabatini D, Fazio S, Cittadini A, Biondi B, Lucariello A, Picano T, Saccà L.
    Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
    [Abstract] [Full Text] [Related]

  • 13. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [Abstract] [Full Text] [Related]

  • 14. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
    da Costa W, Riera AR, Costa Fde A, Bombig MT, de Paola AA, Carvalho AC, Fonseca FH, Luna Filho B, Póvoa R.
    J Electrocardiol; 2008 Oct; 41(6):724-9. PubMed ID: 18954613
    [Abstract] [Full Text] [Related]

  • 15. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.
    Circulation; 2007 Aug 14; 116(7):700-5. PubMed ID: 17664372
    [Abstract] [Full Text] [Related]

  • 16. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 17. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z, Szwed H, Kuch-Wocial A, Kubasik A, Januszewicz W, Krupa-Wojciechowska B, Polak G, Stejfa M, Dvorak I, Balazovjech I, Dubai G, Simon K.
    J Hypertens Suppl; 1998 Aug 12; 16(3):S55-62. PubMed ID: 9747912
    [Abstract] [Full Text] [Related]

  • 18. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.
    Sheiban I, Arcaro G, Covi G, Accardi R, Zenorini C, Lechi A.
    J Cardiovasc Pharmacol; 1987 Aug 12; 10 Suppl 10():S187-91. PubMed ID: 2455130
    [Abstract] [Full Text] [Related]

  • 19. Plasma catecholamine and cardiovascular responses to nifedipine in hypertensives WHO-stage II.
    Lehmann M, Dürr H, Arratibel-Imaz I, Balle C, Keller E, Merkelbach H, Keul J.
    Arzneimittelforschung; 1989 Dec 12; 39(12):1593-6. PubMed ID: 2624611
    [Abstract] [Full Text] [Related]

  • 20. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    Tomiyama M, Horio T, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y.
    J Hum Hypertens; 2007 Mar 12; 21(3):212-9. PubMed ID: 17167525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.